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Background: Malaria remains one of the most important infectious diseases in pregnancy in sub-Saharan Africa.
Whereas seasonal malaria chemoprevention is advocated as public health intervention for children in certain areas
of highly seasonal malaria transmission, the impact of seasonality on malaria in pregnancy has not yet been
investigated for stable, hyper-endemic transmission settings of Equatorial Africa. The aim of this study was to
investigate the influence of seasonality on the prevalence of malaria in pregnancy in Gabon.
Methods: The study was conducted at a rural district hospital in Gabon between January 2008 and December
2011. At first antenatal care visits demographic data, parity, age, and gestational age of pregnant women were
documented and thick blood smears were performed for the diagnosis of malaria. Seasonality and established risk
factors were evaluated in univariate and multivariate analysis for their association with Plasmodium falciparum
infection.
Results: 1,661 pregnant women were enrolled in this study. Participants presenting during high transmission seasons
were at significantly higher risk for P. falciparum infection compared to low transmission seasons (adjusted odds ratio
[AOR] 1.91, 95% confidence interval [CI] 1.39-2.63, p < 0.001). Established risk factors including parity (AOR 0.45,
CI 0.30-0.69, p < 0.001 for multipara versus paucipara) and age (AOR, CI and p-value for women aged 13–17, 18–22,
23–27 and ≥28 years, respectively: AOR 0.59, CI 0.40-0.88; AOR 0.57, CI 0.34-0.97; AOR 0.51, CI 0.29-0.91) were significant
risk factors for P. falciparum infection. High-risk groups including nulli- and primipara and younger women aged
13–17 years showed a disproportionately increased risk for malaria in high transmission seasons from 17% to 64%
prevalence in low and high transmission periods, respectively.
Conclusion: Seasonal variations lead to important differences in the risk for P. falciparum infection in pregnancy in the
setting of central African regions with stable and hyper-endemic malaria transmission. The seasonal increase in malaria
in pregnancy is most pronounced in high-risk groups constituted by young and pauciparous women. The evaluation
of tailored seasonal prevention strategies for these high-risk populations may, therefore, be warranted.
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An estimated 25 million women are at risk to become
infected by Plasmodium falciparum during pregnancy in
sub-Saharan Africa each year [1,2]. Adverse birth out-
comes due to malaria in pregnancy include an increased
prevalence of maternal anaemia, low birth weight, prema-
ture birth and neonatal mortality [3,4]. The World Health
Organization (WHO) recommends a three-pronged stra-
tegy against malaria in pregnancy based on the use of
insecticide-treated bed nets (ITNs), effective case manage-
ment and the administration of intermittent preventive
treatment against malaria in pregnancy (IPTp) with sul-
phadoxine-pyrimethamine (SP) [5,6].
Malaria epidemiology in Gabon is characterized by
stable, hyper-endemic transmission of more than 90%
P. falciparum [7]. In previous surveys little variation in
malaria transmission throughout the year has been ob-
served [7]. The climate is characterized by two rainy and
two dry seasons [8]. Malaria in pregnancy is among the
most important health problems for pregnant women and
the national malaria control programme recommends the
use of ITNs and SP-IPTp. The implementation of IPTp
has led to a considerable decline in P. falciparum infection
in pregnant women in Gabon [9]. Established risk factors
for adverse birth outcome and malaria in pregnancy in-
cluding pauciparity and young age have been equally
established in Gabon [10], however there is no informa-
tion about the influence of seasonal variations in malaria
transmission on the prevalence of malaria in pregnancy in
Gabon.
Based on the observation of high seasonality of malaria
transmission in certain African regions including large
parts of the Sahel, the concept of seasonal malaria che-
moprevention has been developed for children [11]. This
concept advocates administration of amodiaquine (AQ)
and SP only during peak transmission seasons to mini-
mize drug exposure and at the same time maximizing
the protective effect of AQ and SP against malaria. To
date it is unclear whether similar interventions would be
feasible for the prevention of malaria in pregnancy. To
better understand the impact of seasonality on the risk
for malaria in pregnancy in a central African region with
little seasonal variation in malaria transmission we con-
ducted this cross sectional study.
Methods
Study region and study population
This study was conducted in the town of Fougamou (ap-
proximately 8,000 inhabitants) in the rural province of la
Ngounié in Gabon. The region is located in a hilly, rain-
forest covered area with predominance of subsistence
farming as professional activity. The climate is equato-
rial and meteorological data indicate two dry seasons
(December - January and June - September) and tworainy seasons (September - November and February –
May, [8,12]. The average annual temperature is 26°C
and humidity is above 80% [8]. Malaria transmission
is characterized as hyperendemic and P. falciparum
shows high resistance against chloroquine and increa-
sing resistance against SP [13,14]. The Ngounié Medical
Research Centre, a satellite site of the Centre de
Recherches Médicales de Lambaréné [15], is providing
laboratory and parasitological services for the local
governmental hospital, which is the only health care
institution serving the local population.
Pregnant woman presenting for their first antenatal care
visit at the hospital were enrolled in this study. All preg-
nant women received a mother-child health booklet at
presentation and bodyweight, blood pressure, uterine
height and gestational age according to the first day of the
last menstruation were recorded. All women were offered
thick blood smear evaluation performed according to the
Lambaréné method [16] for the diagnosis of malaria
which were read and prove-read by experienced study
professionals guaranteeing high quality data. The follo-
wing data were captured in a central register: age, parity,
date of visit and results of malaria diagnostics. Data were
extracted from this register and entered in an electronic
database. All women with malarial infection received
treatment following current national recommendations.
All thick blood smears were defined as positive if any
asexual forms of P. falciparum were observed. Pregnant
women were categorized as nulli-, primi- and multipara
depending on the number of self-reported previous
pregnancies. Women were categorized in the following
four age groups based on legal age and 5 year intervals:
13–17 years, 18–22 years, 23–27 years, and 28 or more
years of age. With the aim to determine low- and high-
risk seasons for malaria transmission throughout the
year, the proportion of positive blood smears was calcu-
lated for each month during the study period. The
month March (malaria prevalence of 13.9%) was chosen
as cut-off point determining the risk-periods based
on concordant annual trends during the study period:
Low-risk periods were in April and between June and
September (high-risk periods were May and October -
March). Gestational age was calculated according to the
reported first day of last menstruation. Ethical approval
for this retrospective analysis of clinical data that were
obtained from routine clinical records was provided
by the Comité d’Ethique Régional et Independent de
Lambaréné.
Statistical analysis
Data were imported for further analysis into a commer-
cial statistical software package (IBM SPSS Statistics,
version 19.0). Descriptive analyses were performed and a
binary logistic regression model was used to compute
Table 1 Demographic characteristics of study population
and prevalence of malaria in pregnancy in 2008–2011
Demographic characteristics
n (number) 1661
Age* (in years) 23 (17–34;1634)
Age groups stratified
(13–17, 18–22, 23–27, 28+; n) 17%, 32%, 22%, 29%; 1634
Parity* 1 (0–5;1545)
Parity stratified 29%, 22%, 49%; 1545
(NP, PP, MP; n)**
Parity* in age group 1 0 (0–1; 264)
Parity* in age group 2 1 (0–2; 491)
Parity* in age group 3 2 (1–4; 341)
Parity* in age group 4 4 (2–7; 428)
Nullipara* (Age in years) 18 (15–34; 448)
Primipara* (Age in years) 20 (18–26; 333)
Multipara* (Age in years) 28 (22–38; 743)
Trimester*** 24%, 69%, 8%; 769
(1st, 2nd, 3rd; n)
Malaria prevalence
Year n Malaria pos. n (%) 95% CI
2008 325 43 (13%) 10–17%
2009 391 54 (14%) 11–18%
2010 486 93 (19%) 16–23%
2011 444 73 (16%) 13–20%
2008–2011 1646 263 (16%) 14–18%
Differences between the total number of enrolled women and the total
number in specific groups are due to missing data for the particular variable.
*Median (10–90% quantiles; n).
**NP, Nullipara; PP, Primipara; MP, Multipara.
***Percentage of sample.
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for malaria in pregnancy. To minimize exclusion of data
due to missing values binary logistic regression model was
computed for two scenarios: including 1) participants with
all data (parity-, age-, season- and trimester-group) avail-
able for analysis and 2) participants with data for parity,
age and season. Since this sensitivity analysis demon-
strated only minimal differences, the model with fewest
exclusion is shown. Statistical significance was defined by
a likelihood ratio with a p-value below 0.05. 95% confi-
dence intervals (CI) were calculated by the exact bino-
minal method.
Results
Characteristics of study population
Between January 2008 and December 2011 a total of
1,661 pregnant women attended the hospital for their
first antenatal care visit. Table 1 shows the demographic
characteristics of the participating women. The total
number of positive blood smears was 263 (16%) during
the study period and proportions of P. falciparum infec-
tions diagnosed at first antenatal care visit are also given
in Table 1. Mean parasitaemia of all positive blood
smears was 1075 per microlitre blood. The distribution
of risk factors (parity, gestational and maternal age)
among the study population did not vary depending on
the month of presentation during the study-period.
Risk factor analysis for malaria in pregnancy
Parity, age and season were significantly associated with
the risk for malaria computed by the binary logistic re-
gression (Table 2). Multipara were significantly less likely
to be diagnosed with malaria compared to nullipara and
primipara. When combining nulli- and primipara in one
group there was a statistically significant difference com-
pared to multipara in the prevalence of malaria (AOR
0.45, CI 0.30-0.69, p < 0.001, not shown in Table 2).
Malaria prevalence decreased significantly from age
group 1 to age group 4 and pregnant women attending
antenatal care visits in their first trimester had the highest
risk for P. falciparum infection with a prevalence of 23%
(n = 40). In binary logistic regression for gestational age
defined as an ordinal variable, the model showed a signi-
ficant association of gestational age with a decrease in
malaria positivity from the first to the third trimester
(AOR 0.66, CI 0.45-0.97, p = 0.035, not shown in Table 2).
Impact of seasonality on the risk for malaria in pregnancy
The dashed curve (drawn in grey) in Figure 1 shows the
distribution of the malaria prevalence in pregnancy
aggregated by month of presentation for the first ante-
natal care visit for the study period 2008–2011. Monthly
proportions for P. falciparum infection ranged from 8%
(n = 7) in August to 24% (n = 39) in January. In thecourse of the year malaria positivity declined from January
to April to 12% (n = 17), increased thereafter to 16% (n =
19) in May for a further decline to 11% (n = 12) in June.
Malaria prevalence increased again between September
and November to 20% (n = 31). This pattern was compar-
able for all years during the study period. The variation in
the prevalence of malaria in pregnancy depending on the
annual season was statistically significant as assessed in lo-
gistic regression analysis (high- versus low-risk season:
AOR 1.91, CI 1.39-2.63, p < 0.001).
Impact of seasonality on the risk for malaria in pregnancy
in high-risk groups
The solid curve and the dashed curve (drawn in black)
in Figure 1 depicts the distribution of malaria prevalence
in pregnancy from 2008–2011 for high-risk pregnant
women including young (13–17 years of age), nulli- and
Table 2 Results of the binary logistic regression: malaria prevalence in different risk groups (2008–2011)
n Malaria pos. n (%) OR* (95% CI) AOR** (95% CI) p-value**
Parity Nullipara 442 114 (26%) 1.00 1.00 Ref
Primipara 330 59 (18%) 0.63 (0.44–0.89) 0.79 (0.53–1.17) 0.231
Multipara 738 66 (9%) 0.28 (0.20–0.39) 0.39 (0.24–0.64) < 0.001
Age in years 13–17 262 77 (29%) 1.00 1.00 Ref
18–22 484 83 (17%) 0.50 (0.35–0.71) 0.59 (0.40–0.88) 0.010
23–27 339 40 (12%) 0.32 (0.21–0.49) 0.57 (0.34–0.97) 0.038
28+ 425 39 (9.2%) 0.24 (0.16–0.37) 0.51 (0.29–0.91) 0.023
Season Low-risk 547 61 (11%) 1.00 1.00 Ref
High-risk 963 178 (19%) 1.81 (1.32–2.47) 1.91 (1.39–2.63) < 0.001
Trimester 1 163 36 (22%) 1.00 1.00 Ref
2 496 76 (15%) 0.64 (0.41–0.99) 0.68 (0.43–1.08) 0.105
3 57 6 (11%) 0.42 (0.16–1.04) 0.42 (0.16–1.08) 0.070
*OR (odds ratio).
**AOR (adjusted odds ratio and p-value, calculated by the binary logistic regression model).
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above 17 years, at least two pregnancies). In every month
the high-risk group (solid curve) had a markedly higher
prevalence of P. falciparum infection than the low-risk
group (dashed curve). Highest prevalence was observed in
January (64%) and lowest in September (17%), indicating a
higher degree of variation in this high-risk group com-
pared to the general study population.Figure 1 Seasonal prevalence of malaria in pregnancy of high-risk ve
malaria prevalence is aggregated by month for all the years 2008 until 201
nulli-, primipara pregnant women and age group 1. The dashed curve (dra
tervals are given as error bars. The dashed curve (drawn in black) is a low-r
pregnant women by month is given for all groups (n* = high-risk group, n#Discussion
This study demonstrates that marked seasonal variations
in the prevalence of P. falciparum infection in pregnancy
occurs in a rural Central African community in Gabon.
The finding of an AOR of 1.91 seems surprisingly high on
the background of perennial, stable and hyper-endemic
malarial transmission in Gabon [7]. Besides seasonality
several other risk factors including parity and maternalrsus low-risk groups during the study period 2008–2011. The
1. The solid curve (drawn in black) is a high-risk group composed of
wn in grey) includes the whole study population, 95% confidence in-
isk group composed of multipara and age group 2–4. The number of
= whole study population, n ~ = low-risk group).
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the risk for P. falciparum infection. Whereas these data
confirm previous findings [8,10,17-22], the sub-analysis of
a high-risk group of young and pauciparous women
showed even more pronounced seasonal variations in
malaria prevalence with maximum monthly prevalence
rates varying from 64% in January to 17% in September.
This potentiating effect of seasonality on established risk
factors in the setting of perennial stable malaria transmis-
sion has not yet been well described. The epidemiological
description of these sub-groups of pregnant women with
disproportionally high-risk for P. falciparum infection
may emphasize the need of effective prevention programs
in this high-risk group for the prevention of malaria in
pregnancy.
To date SP-IPTp is - besides the use of ITNs and case
management - the recommended strategy of the WHO
in most of sub-Saharan African countries to combat
malaria in pregnancy [6]. Current recommendations
advocate for the provision of at least three therapeutic
doses of SP to all pregnant women after the first trimes-
ter [5]. The markedly increased risk for malaria in preg-
nancy in certain risk groups such as very young women,
women in their first pregnancy and women having preg-
nancies during high transmission seasons is not reflected
by the uniform recommendation for SP-IPTp in sub-
Saharan Africa [5,6]. However, these data may be seen as
supportive evidence justifying further clinical evaluation
of tailored prevention strategies based on seasonal and
demographic risk stratification.
Whereas our study aptly analyses risk factors and their
association with malaria in pregnancy, several limitations
of the study design need to be acknowledged. Firstly, this
study is designed as a cross-sectional survey collecting
data only at the first antenatal care visit. Therefore no ro-
bust estimate on the incidence of P. falciparum infections
in the course of pregnancy can be drawn from this study.
Similarly, data have been obtained from a hospital registry
and potential problems in data accuracy can therefore not
be excluded. Finally, the influence of concomitant intake
of anti-malarial drugs cannot be ruled out. However, since
all women presented for their first antenatal care visit,
no major confounding by the intake of SP-IPTp is
anticipated.Conclusion
Even in Central African regions with stable, perennial and
hyper-endemic malaria transmission, seasonality leads to
important variations in the prevalence of malaria in preg-
nancy. These variations are even more pronounced in
high-risk groups of young and pauciparous women. These
findings evoke reflexions on the potential usefulness of
more individualized prevention strategies based on a risk-benefit analysis, for low- and high-risk groups among
pregnant women in sub-Saharan Africa.
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